Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Erectile Rehabilitation After Rectal Cancer Surgery
NCT06123156Phase 3Recruiting
- Sponsor
- Rouen University Hospital
- Start
- Sep 2025
- Primary completion
- Feb 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in erectile dysfunction (ED) comparing Sildenafil with Placebo (2 arms). Primary endpoint: Patient's response at 12 months. Started Sep 2025; status: recruiting.
02
Drugs
sildenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT06123156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06123156.